Neumora Therapeutics Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$0.73

-0.02 (-2.67%)

As of Sep 20, 10:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 12 80%

Hold 2 13%

Sell 1 7%

Price Target

Analyst Price Target +2,275.3% upside

Low Target $11.85

Average Target $17.34

High Target $21.76

Current Price $0.73

Current
$0.73

Target
$17.34

$11.85 $17.34 avg $21.76

Scenario Analysis

Bear Case

$11.85

1,523.3%

Low target

Base Case

$17.34

+2,275.3%

Avg target

Bull Case

$21.76

+2,880.8%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$3.65

-80.0% from high

52-Week Low

$0.73

+-0.2% from low

Target vs 52W High

$17.34

+375.1% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+15.6%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.3%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+7.6%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+20.3%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+185.4%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-37.1%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+193.1%